Menu
Back to User profile » Dr Yonghong Xiao
Papers published by Dr Yonghong Xiao:
Improving Blood Culture Quality with a Medical Staff Educational Program: A Prospective Cohort Study
Chen Y, Dai Y, Zhou Y, Huang Y, Jin Y, Geng Y, Ji B, Xu R, Zhu W, Hu S, Li Z, Liang J, Xiao Y
Infection and Drug Resistance 2023, 16:3607-3617
Published Date: 7 June 2023
Prevalent Dominant Acinetobacter baumannii ST191/195/208 Strains in Bloodstream Infections Have High Drug Resistance and Mortality
Niu T, Guo L, Kong X, He F, Ru C, Xiao Y
Infection and Drug Resistance 2023, 16:2417-2427
Published Date: 24 April 2023
Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
Zhu Y, Xiao T, Wang Y, Yang K, Zhou Y, Luo Q, Shen P, Xiao Y
Infection and Drug Resistance 2021, 14:5385-5393
Published Date: 14 December 2021
Acquisition of the mcr-1 Gene Lowers the Target Mutation to Impede the Evolution of a High-Level Colistin-Resistant Mutant in Escherichia coli
Huang C, Shi Q, Zhang S, Wu H, Xiao Y
Infection and Drug Resistance 2021, 14:3041-3051
Published Date: 10 August 2021
Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
Dai Y, Chang W, Zhou X, Yu W, Huang C, Chen Y, Ma X, Lu H, Ji R, Ying C, Wang P, Liu Z, Yuan Q, Xiao Y
Drug Design, Development and Therapy 2021, 15:2899-2905
Published Date: 6 July 2021
Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China
Wu X, Huang C, Wang H, Ji J, Ying C, Xiao Y
Drug Design, Development and Therapy 2021, 15:2593-2603
Published Date: 17 June 2021
Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
Wang Y, Xiao T, Zhu Y, Ye J, Yang K, Luo Q, Shen P, Xiao Y
Infection and Drug Resistance 2020, 13:3583-3592
Published Date: 13 October 2020
In vitro reduction of colistin susceptibility and comparative genomics reveals multiple differences between MCR-positive and MCR-negative colistin-resistant Escherichia coli
Luo Q, Niu T, Wang Y, Yin J, Wan F, Yao M, Lu H, Xiao Y, Li L
Infection and Drug Resistance 2019, 12:1665-1674
Published Date: 12 June 2019
Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation
Yu W, Ji J, Xiao T, Ying C, Fang J, Shen P, Xiao Y
Drug Design, Development and Therapy 2017, 11:1951-1956
Published Date: 28 June 2017